Objective Capital Management’s Johnson & Johnson JNJ Stock Holding History

Objective Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Sell	1,120 -10	-0.9%	-$2.33K	0.25%	78
2026 Q1	$276K	Buy	+1,130	New	+$263K	0.28%	74
2025 Q1	–	Sell	-1,800	Closed	-$260K	–	113
2024 Q4	$260K	Sell	1,800 -362	-17%	-$56.1K	0.17%	115
2024 Q3	$350K	Buy	+2,162	New	+$344K	0.21%	104
2024 Q1	$374K	Sell	2,362 -108	-4%	-$17.2K	0.25%	86
2023 Q4	$387K	Sell	2,470 -201	-8%	-$30.8K	0.3%	72
2023 Q3	$416K	Sell	2,671 -794	-23%	-$131K	0.37%	60
2023 Q2	$574K	Buy	3,465 +3	+0.1%	+$484	0.5%	46
2023 Q1	$537K	Sell	3,462 -29	-0.8%	-$4.68K	0.49%	48
2022 Q4	$617K	Buy	3,491 +125	+4%	+$21.6K	0.61%	44
2022 Q3	$550K	Buy	3,366 +33	+1%	+$5.58K	0.59%	42
2022 Q2	$592K	Buy	3,333 +433	+15%	+$77.1K	0.6%	44
2022 Q1	$514K	Sell	2,900 -100	-3%	-$17K	0.4%	59
2021 Q4	$513K	Buy	+3,000	New	+$491K	0.36%	59

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Objective Capital Management's JNJ Position: Q2 2026 in Review

Objective Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.88% in Q2 2026, selling an estimated $2.33K and leaving 1,120 shares worth $284K. The position accounts for 0.25% of the portfolio, ranked #78.

Objective Capital Management first reported a position in JNJ in Q4 2021 and has held it in 14 quarters since. The position peaked at $617K in Q4 2022. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Objective Capital Management held 1,120 shares of Johnson & Johnson worth $284K as of Q2 2026.
Objective Capital Management sold 10 Johnson & Johnson shares in Q2 2026, an estimated $2.33K.
Johnson & Johnson made up 0.25% of Objective Capital Management's portfolio in Q2 2026, its #78 holding.
Objective Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 14 quarters since.
Objective Capital Management's Johnson & Johnson position peaked at $617K in Q4 2022.
1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Objective Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.